The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in ...
The American Society of Clinical Oncology (ASCO) has fully updated its antiemetic guideline for patients with cancer receiving chemotherapy and radiation therapy for the first time since 2015. The ...
ASCO releases guidelines for antiemetics in oncology The updated guidelines will help clinicians prevent and manage nausea and vomiting caused by antineoplastic agents or radiation therapy in cancer ...
Leveraging Artificial Intelligence to Uncover Symptom Burden in Palliative Care: Analysis of Nonscheduled Visits Using a Phi-3 Small Language Model This was a single-center, phase III, prospective ...
PURPOSE: The use of serotonin 5-hydroxytryptamine type 3 receptor antagonists has substantially reduced, but not eliminated, nausea and vomiting in cancer chemotherapy. This study sought to ...
Chemotherapy-induced nausea and vomiting (CINV) represents one of the most distressing and debilitating side effects experienced by cancer patients undergoing treatment, significantly impacting ...
Slower infusion rates of antiemetic drugs may help manage nausea and vomiting in patients with gastric or gastroesophageal junction cancers. Slower infusion rates of antiemetic combination drugs have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results